These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25505191)

  • 41. Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.
    Besag FMC; Vasey MJ; Salim I
    CNS Drugs; 2021 May; 35(5):507-526. PubMed ID: 33880739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alcohol Use Disorders Identification Test (AUDIT) scores are elevated in antipsychotic-induced hyperprolactinaemia.
    Lawford BR; Barnes M; Connor JP; Heslop K; Nyst P; Young RM
    J Psychopharmacol; 2012 Feb; 26(2):324-9. PubMed ID: 21262859
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between a slow-release oral preparation of bromocriptine and regular bromocriptine in patients with hyperprolactinemia: a double blind, double dummy study.
    Moro M; Maraschini C; Toja P; Masala A; Alagna S; Rovasio PP; Ginanni A; Lancranjan I; Cavagnini F
    Horm Res; 1991; 35(3-4):137-41. PubMed ID: 1806467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychiatric Patients with Antipsychotic Drug-Induced Hyperprolactinemia and Menstruation Disorders.
    Takechi K; Yoshioka Y; Kawazoe H; Tanaka M; Takatori S; Kobayashi M; Matsuoka I; Yanagawa H; Zamami Y; Imanishi M; Ishizawa K; Tanaka A; Araki H
    Biol Pharm Bull; 2017; 40(10):1775-1778. PubMed ID: 28966250
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group.
    Webster J; Piscitelli G; Polli A; Ferrari CI; Ismail I; Scanlon MF
    N Engl J Med; 1994 Oct; 331(14):904-9. PubMed ID: 7915824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.
    Charan A; Shewade DG; Rajkumar RP; Chandrasekaran A
    Psychiatry Res; 2016 Jun; 240():209-213. PubMed ID: 27111215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-endorphin levels in women with elevated prolactin and following bromocriptine therapy.
    Lox CD; Pau KY
    Gen Pharmacol; 1993 Sep; 24(5):1231-3. PubMed ID: 8270182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine].
    Barszcz Z; Mucha S; Rabe-Jabłońska J
    Psychiatr Pol; 2008; 42(4):595-607. PubMed ID: 19189603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postprandial prolactin suppression appears absent in antipsychotic-treated male patients.
    Coello K; Broberg BV; Bak N; Madsen A; Mortensen HB; Søgaard B; Szecsi PB; Knop FK; Lublin H; Ebdrup BH
    Psychoneuroendocrinology; 2015 Oct; 60():1-6. PubMed ID: 26094073
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.
    Young RM; Lawford BR; Barnes M; Burton SC; Ritchie T; Ward WK; Noble EP
    Br J Psychiatry; 2004 Aug; 185():147-51. PubMed ID: 15286066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
    Tsuboi T; Bies RR; Suzuki T; Mamo DC; Pollock BG; Graff-Guerrero A; Mimura M; Uchida H
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():178-82. PubMed ID: 23727135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of bromocriptine on affect and libido in hyperprolactinemia.
    Koppelman MC; Parry BL; Hamilton JA; Alagna SW; Loriaux DL
    Am J Psychiatry; 1987 Aug; 144(8):1037-41. PubMed ID: 3300375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind study.
    Schulz A; Lancranjan I; Schürmeyer T; Schuppert F; Hesch RD; von zur Mühlen A; Brabant G
    J Endocrinol Invest; 1991 Jun; 14(6):469-74. PubMed ID: 1774443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy, tolerability and safety of Parlodel LAR versus Parlodel in hyperprolactinemia.
    Bolanowski M; Milewicz A; Bohdanowicz-Pawlak A; Bednarek-Tupikowska G; Jedrzejak JA; Lancranjan I
    Endokrynol Pol; 1993; 44(4):467-76. PubMed ID: 8055815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.